IDiyas

For the Inventor, By the Inventor

Daejeon, South Korea

Hye-Shin Chung

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:

goldMedal9 out of 14 
 
Alteogen, Inc.
 patents

Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12371683 - Hyaluronidase variants and pharmaceutical composition comprising the same (2025-07-29),
2. 12090210 - Antibody-drug conjugate comprising modified antibody (2024-09-17),
3. 11866492 - Antibody specifically binding to FOLR1 and uses thereof (2024-01-09),
4. 11235065 - Antibody-drug conjugate comprising modified antibody (2022-02-01),
5. 9982032 - Stable liquid formulation of fusion protein with IgG Fc domain (2018-05-29),
6. 9821059 - Composition for stabilizing protein and pharmaceutical formulation comprising the same (2017-11-21),
7. 9814782 - Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same (2017-11-14),
8. 9051395 - Alpha-1 antitrypsin variant, preparation method thereof and use thereof (2015-06-09),
9. 9012606 - In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using same (2015-04-21),

Title: Hye-Shin Chung: Innovator in Protein Engineering

Introduction

Hye-Shin Chung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of protein engineering, particularly in the development of innovative pharmaceutical compositions. With a total of nine patents to his name, Chung's work has the potential to impact various medical applications.

Latest Patents

Chung's latest patents include groundbreaking inventions such as hyaluronidase variants and an antibody-drug conjugate. The hyaluronidase variants focus on enhancing the enzymatic activity and thermal stability of human hyaluronidase, which is crucial for hydrolyzing hyaluronic acid. This invention specifically addresses amino acid residue substitutions that improve the enzyme's functionality. Additionally, his work on antibody-drug conjugates involves a modified antibody that significantly increases the conjugation yield of drugs, showcasing his innovative approach to therapeutic development.

Career Highlights

Chung is currently associated with Alteogen, Inc., where he continues to push the boundaries of protein engineering. His expertise in this field has led to advancements that could revolutionize treatment methodologies in medicine. His dedication to research and development is evident in the quality and impact of his patents.

Collaborations

Chung collaborates with talented individuals such as Soon Jae Park and Sunbae Lee, contributing to a dynamic research environment. These collaborations enhance the innovative potential of their projects and foster a culture of creativity and excellence.

Conclusion

Hye-Shin Chung is a distinguished inventor whose work in protein engineering is paving the way for new medical advancements. His contributions through patents and collaborations highlight his commitment to innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…